Analyst Reco. Boston Scientific Corporation

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 20:25:41 14/07/2025 BST			5-day change	1st Jan Change
104.40 ^USD	+1.16%		+0.59%	+16.93%

07-07	Boston Scientific Says Farapulse Receives FDA Approval for Atrial Fibrillation	MT
07-07	Boston Scientific Corporation Receives U.S. Food and Drug Administration Approval to Expand the Instructions for Use Labeling for the Farapulse Pulsed Field Ablation System	CI

Analyst Reco.

Jefferies Adjusts Price Target on Boston Scientific to $125 From $122	06-20	MT
Leerink Partners Initiates Boston Scientific at Outperform With $118 Price Target	06-16	MT
Goldman Sachs Adjusts Price Target on Boston Scientific to $119 From $117, Maintains Buy Rating	06-02	MT
Citigroup Adjusts Price Target on Boston Scientific to $125 From $119, Maintains Buy Rating	05-22	MT
Morgan Stanley Adjusts Price Target on Boston Scientific to $125 From $120, Maintains Overweight Rating	05-15	MT
Nephron Research Adjusts Boston Scientific Price Target to $125 From $120	04-28	MT
Barclays Raises Price Target on Boston Scientific to $125 From $118	04-24	MT
Oppenheimer Adjusts Price Target on Boston Scientific to $110 From $106, Maintains Market Perform Rating	04-24	MT
Goldman Sachs Adjusts Price Target on Boston Scientific to $117 From $116, Maintains Buy Rating	04-24	MT
Baird Adjusts Price Target on Boston Scientific to $120 From $115, Maintains Outperform Rating	04-24	MT
Jefferies Adjusts Price Target on Boston Scientific to $122 From $120, Maintains Buy Rating	04-24	MT
Raymond James Adjusts Price Target on Boston Scientific to $121 From $122, Maintains Strong Buy Rating	04-24	MT
Truist Adjusts Price Target on Boston Scientific to $117 From $113, Maintains Buy Rating	04-24	MT
Bernstein Adjusts Price Target on Boston Scientific to $124 From $121, Maintains Outperform Rating	04-24	MT
Needham Adjusts Price Target on Boston Scientific to $115 From $113, Maintains Buy Rating	04-24	MT
William O'Neil Initiates Boston Scientific at Buy	04-24	MT
BTIG Adjusts Price Target on Boston Scientific to $124 From $120	04-23	MT
RBC Raises Price Target on Boston Scientific to $120 From $116	04-23	MT
Evercore ISI Adjusts Boston Scientific Price Target to $112 From $110, Maintains Outperform Rating	04-23	MT
Needham Upgrades Boston Scientific to Buy From Hold, Price Target is $113	04-16	MT
Needham Upgrades Boston Scientific to Buy From Hold, Sets $113 Price Target	04-16	MT
Truist Cuts Price Target on Boston Scientific to $113 From $120, Keeps Buy Rating	04-11	MT
Baird Cuts Price Target on Boston Scientific to $115 From $120, Keeps Outperform Rating	04-10	MT
Citigroup Adjusts Boston Scientific Price Target to $119 From $122, Maintains Buy Rating	04-07	MT
Evercore ISI Adjusts Boston Scientific Price Target to $110 From $112, Maintains Outperform Rating	04-02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Boston Scientific exceeds analysts' estimates for seven straight quarters

June 26, 2025 at 12:11 pm